- Home
- ROIV vs RL Comparison
ROIV vs RL Comparison
Compare ROIV & RL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | RL |
|---|---|---|
| Founded | 2014 | 1967 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.0B | 20.2B |
| IPO Year | 2021 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ROIV | RL |
|---|---|---|
| Price | $28.21 | $364.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 17 |
| Target Price | $28.94 | ★ $406.75 |
| AVG Volume (30 Days) | ★ 5.8M | 725.6K |
| Earning Date | 05-28-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | N/A | ★ 30.15 |
| EPS | N/A | ★ 15.11 |
| Revenue | $8,260,000.00 | ★ $8,114,500,000.00 |
| Revenue This Year | N/A | $15.92 |
| Revenue Next Year | $744.61 | $5.80 |
| P/E Ratio | ★ N/A | $24.24 |
| Revenue Growth | N/A | ★ 14.63 |
| 52 Week Low | $10.71 | $260.89 |
| 52 Week High | $32.79 | $393.41 |
Technical Indicators
Market Signals| Indicator | ROIV | RL |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 53.51 |
| Support Level | $26.95 | $350.49 |
| Resistance Level | $30.10 | $383.30 |
| Average True Range (ATR) | 1.10 | 10.98 |
| MACD | -0.15 | 2.79 |
| Stochastic Oscillator | 7.69 | 63.87 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About RL Ralph Lauren Corporation
Founded by designer Ralph Lauren (current executive chairman and chief creative officer) in 1967 in New York City, Ralph Lauren Corp. designs, markets, and distributes lifestyle merchandise in North America, Europe, and Asia. Best known for its iconic polo shirts, its products also include other types of apparel, footwear, eyewear, jewelry, handbags, home goods, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, and Lauren Ralph Lauren. Distribution channels for Ralph Lauren include wholesale (department stores and specialty stores), retail (company-owned retail stores and e-commerce), and licensing.